PRESENTATION

Q4 2023 — Results presentation

Q4 2023PDF · 24 pages1.3 MB
Public
ASML 2023 Fourth-Quarter and Full-Year results
Veldhoven, the Netherlands
January 24, 2024
ASML reports €27.6 billion net sales and €7.8 billion net income in 2023
2024 expected to be a transition year with sales similar to 2023

-- 1 of 24 --

Public
Page 2	January 24, 2024
• Investor key messages
• Business summary
• Outlook
• Financial statements
Agenda

-- 2 of 24 --

Public
Page 3	January 24, 2024
Investor key messages

-- 3 of 24 --

Public
Page 4	January 24, 2024
Investor key messages
• Global megatrends in the electronics industry, supported by a highly profitable and fiercely
innovative ecosystem, are expected to continue to fuel growth across the semiconductor market
• Growth in semiconductor end markets and increasing lithography intensity are driving demand for
our products and services
• ASML’s comprehensive product portfolio is aligned with our customers’ roadmaps, delivering cost
effective solutions in support of all applications from leading edge to mature nodes
• Based on different market scenarios1 as presented during our Investor Day in November 2022, we
modeled an opportunity to reach annual revenue in 2025 between approximately €30 billion and
€40 billion, with a gross margin between approximately 54% and 56% and in 2030 an annual
revenue between approximately €44 billion and €60 billion, with a gross margin between
approximately 56% and 60%
• ASML and its supply chain partners are actively adding and improving capacity to meet current and
future customer demand
• We continue to execute our ESG Sustainability strategy and will share the latest progress and
actions to reach our targets in our integrated Annual Report 2023, to be published on February 14,
2024
• We expect to continue to return significant amounts of cash to our shareholders through a
combination of growing dividends and share buybacks
1 based on third party research and our assumptions

-- 4 of 24 --

Public
Page 5	January 24, 2024
Business summary

-- 5 of 24 --

Public
Page 6	January 24, 2024
2023 - Business summary
ASML achieved a sales growth of 30%, reflecting the continued strong global demand for our products:
• Net sales grew to €27.6 billion at 51.3% gross margin
• Net income at €7.8 billion resulted in an EPS of €19.91
EUV lithography:
• EUV system sales grew 30% to €9.1 billion, recognized revenue on 53 systems and shipped 42 systems
• Shipped the first modules of the first High NA EUV EXE:5000 system
DUV lithography:
• DUV system sales grew 60% to €12.3 billion, recognized revenue on 396 systems of which 32% immersion systems
• Shipped the first NXT:1980Fi immersion systems as well as the XT:400M i-line systems
Applications:
• Our Metrology & Inspection systems sales declined 19% to €536 million due to lower YieldStar systems sales
• Shipped the first YieldStar 500 systems
Installed Base1:
• Our Installed Base business declined 2% to €5.6 billion due to lower upgrade business
Capital return:
• Returned €3.3 billion to shareholders through dividends and share buybacks
1 Installed Base Management equals our net service and field option sales

-- 6 of 24 --

Public
Page 7	January 24, 2024
Shipped 1st modules of 1st High NA EUV EXE:5000 system
Increased NA enables cost effective shrink with increased transistor density

-- 7 of 24 --

Public
Page 8	January 24, 2024
1 Installed Base Management equals our net service and field option sales
2 Income from operations as a percentage of Total net sales
3 Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.
Q4 results summary
• Net sales of €7.2 billion, net system sales of €5.7 billion, Installed Base
Management1 sales of €1.6 billion
• Gross margin of 51.4%
• Operating margin2 of 33.1%
• Net income as a percentage of net sales of 28.3%
• Earnings per share (basic) of €5.21
• Net bookings3 of €9.2 billion
◦ including EUV bookings of €5.6 billion
Numbers have been rounded for readers' convenience.

-- 8 of 24 --

Public
Page 9	January 24, 2024
Net system sales breakdown (Quarterly)
Q4’23
Net system sales
€5,683 million
Q3’23
Net system sales
€5,308 million

-- 9 of 24 --

Public
Page 10	January 24, 2024
2023
Net system sales
€21,939 million
2022
Net system sales
€15,430 million
Net system sales breakdown (Yearly)

-- 10 of 24 --

Public
Page 11	January 24, 2024
Logic
Memory
Installed Base
Management1
1 Installed Base Management equals our net service and field option sales
Total net sales € million by End-use

-- 11 of 24 --

Public
Page 12	January 24, 2024
Net systems bookings1 activity by End-use
Q4’23 net system bookings
€9,186 million
Q3’23 net system bookings
€2,602 million
1 Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

-- 12 of 24 --

Public
Page 13	January 24, 2024
• ASML intends to declare a total dividend for the year 2023 of €6.10 per ordinary share. An
interim dividend of €1.45 per ordinary share will be made payable on February 14, 2024
• Recognizing this (third) interim dividend and the two interim dividends of €1.45 per ordinary
share paid in 2023, this leads to a final dividend proposal to the General Meeting of €1.75 per
ordinary share
• In Q4 2023 no shares were purchased
Capital return to shareholders
Share buyback
Dividend paid
Third interim and final dividend for a year are paid in the subsequent year
Total dividend
Interim dividend
(paid)
Interim dividend
(to be paid)
Proposed final
dividend

-- 13 of 24 --

Public
Page 14	January 24, 2024
Outlook

-- 14 of 24 --

Public
Page 15	January 24, 2024
Outlook
Q1
• Net sales between €5.0 billion and €5.5 billion, including
◦ Installed Base Management1 sales of around €1.3 billion
• Gross margin between 48% and 49%
• R&D costs of around €1,070 million
• SG&A costs of around €300 million
2024
• Similar net sales with a slightly lower gross margin, relative to 2023
• Estimated annualized effective tax rate between 16% and 17%
1 Installed Base Management equals our net service and field option sales

-- 15 of 24 --

Public
Page 16	January 24, 2024
Financial Statements

-- 16 of 24 --

Public
Page 17	January 24, 2024
2019 2020 2021 2022 2023
Net sales 11,820 13,979 18,611 21,173 27,559
Gross profit 5,280 6,798 9,809 10,700 14,136
Gross margin % 44.7 48.6 52.7 50.5 51.3
Other income 1 — — 214 — —
R&D costs (1,968) (2,201) (2,547) (3,254) (3,981)
SG&A costs (521) (545) (726) (946) (1,113)
Income from operations 2,791 4,051 6,750 6,501 9,042
Operating income as a % of net sales 23.6 29.0 36.3 30.7 32.8
Net income 2,592 3,554 5,883 5,624 7,839
Net income as a % of net sales 21.9 25.4 31.6 26.6 28.4
Earnings per share (basic) € 6.16 8.49 14.36 14.14 19.91
Earnings per share (diluted) € 6.15 8.48 14.34 14.13 19.89
Lithography systems sold (units) 2 229 258 309 345 449
Net bookings 3 11,740 11,292 26,240 30,674 20,040
These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.
Consolidated statements of operations € million
Year on Year
1 Other income includes the gain on the sale of Berliner Glas subsidiaries
2 Lithography systems do not include metrology and inspection systems
3 The sum of quarterly net bookings over the full year. Our 2019 systems net bookings include 1 EUV and 1 DUV order shipped to our collaborative Research Center (Imec). These
systems were not recognized in revenue.

-- 17 of 24 --

Public
Page 18	January 24, 2024
Consolidated statements of operations € million
Quarter on Quarter
Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023
Net sales 6,430 6,746 6,902 6,673 7,237
Gross profit 3,311 3,413 3,544 3,462 3,717
Gross margin % 51.5 50.6 51.3 51.9 51.4
R&D costs (906) (948) (1,000) (992) (1,041)
SG&A costs (280) (260) (281) (288) (284)
Income from operations 2,125 2,205 2,263 2,182 2,392
Operating income as a % of net sales 33.0 32.7 32.8 32.7 33.1
Net income 1,817 1,956 1,942 1,893 2,048
Net income as a % of net sales 28.2 29.0 28.1 28.4 28.3
Earnings per share (basic) € 4.60 4.96 4.93 4.81 5.21
Earnings per share (diluted) € 4.60 4.95 4.93 4.81 5.20
Lithography systems sold (units) 1 106 100 113 112 124
Net bookings 2 6,316 3,752 4,500 2,602 9,186
1 Lithography systems do not include metrology and inspection systems.
2 Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.
These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.

-- 18 of 24 --

Public
Page 19	January 24, 2024
2019 2020 2021 2022 2023
Cash and cash equivalents, beginning of period 3,121 3,532 6,049 6,952 7,268
Net cash provided by (used in) operating activities 3,276 4,628 10,847 8,487 5,443
Net cash provided by (used in) investing activities (1,158) (1,352) (72) (1,029) (2,689)
Net cash provided by (used in) financing activities (1,712) (753) (9,892) (7,138) (3,003)
Effect of changes in exchange rates on cash 5 (5) 20 (4) (14)
Net increase (decrease) in cash and cash equivalents 411 2,517 903 316 (263)
Cash and cash equivalents, end of period 3,532 6,049 6,952 7,268 7,005
Short-term investments 1,186 1,302 638 108 5
Cash and cash equivalents and short-term investments 4,718 7,351 7,590 7,376 7,010
Purchases of property, plant and equipment and intangible assets (885) (1,001) (940) (1,319) (2,196)
Free cash flow 1 2,391 3,627 9,906 7,168 3,247
1 Free cash flow, which is a non-GAAP measure, is defined as net cash provided by (used in) operating activities minus purchases of Property, plant and equipment and
intangible assets, see US GAAP Consolidated Financial Statements
These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.
Consolidated statements of cash flows € million
Year on Year

-- 19 of 24 --

Public
Page 20	January 24, 2024
Consolidated statements of cash flows € million
Quarter on Quarter
Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023
Cash and cash equivalents, beginning of period 3,153 7,268 6,648 6,341 4,976
Net cash provided by (used in) operating activities 5,351 734 385 1,128 3,197
Net cash provided by (used in) investing activities (364) (436) (545) (1,090) (617)
Net cash provided by (used in) financing activities (859) (916) (137) (1,406) (545)
Effect of changes in exchange rates on cash (13) (2) (10) 3 (6)
Net increase (decrease) in cash and cash equivalents 4,115 (620) (307) (1,365) 2,029
Cash and cash equivalents, end of period 7,268 6,648 6,341 4,976 7,005
Short-term investments 108 5 5 5 5
Cash and cash equivalents and short-term investments 7,376 6,653 6,346 4,981 7,010
Purchases of property, plant and equipment and intangible assets (466) (539) (544) (510) (602)
Free cash flow 1 4,885 194 (161) 618 2,595
1 Free cash flow, which is a non-GAAP measure, is defined as net cash provided by (used in) operating activities minus purchases of Property, plant and equipment and
intangible assets, see US GAAP Consolidated Financial Statements
These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.

-- 20 of 24 --

Public
Page 21	January 24, 2024
Assets 2019 2020 2021 2022 2023
Cash & cash equivalents and short-term investments 4,718 7,352 7,590 7,376 7,010
Net accounts receivable and finance receivables 2,773 3,421 4,597 6,680 5,774
Contract assets 231 119 165 132 240
Inventories, net 3,809 4,569 5,179 7,200 8,851
Loan receivable — — 124 364 929
Other assets 1,673 1,753 1,886 2,383 2,230
Tax assets 624 739 1,141 1,706 2,873
Equity method investments 833 821 893 924 920
Goodwill 4,541 4,629 4,556 4,556 4,589
Other intangible assets 1,105 1,049 952 842 742
Property, plant and equipment 1,999 2,470 2,983 3,944 5,493
Right-of-use assets 324 345 165 193 307
Total assets 22,630 27,267 30,231 36,300 39,958
Liabilities and shareholders' equity
Current liabilities 4,694 6,604 12,298 17,983 16,275
Non-current liabilities 5,344 6,798 7,792 9,506 10,231
Shareholders' equity 12,592 13,865 10,141 8,811 13,452
Total liabilities and shareholders' equity 22,630 27,267 30,231 36,300 39,958
These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.
Consolidated balance sheets € million
Year on Year

-- 21 of 24 --

Public
Page 22	January 24, 2024
Consolidated balance sheets € million
Quarter on Quarter
Assets Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023
Cash & cash equivalents and short-term investments 7,376 6,653 6,346 4,981 7,010
Net accounts receivable and finance receivables 6,680 4,862 5,686 5,682 5,774
Contract assets 132 236 193 267 240
Inventories, net 7,200 7,392 7,734 8,379 8,851
Loan receivable 364 364 364 921 929
Other assets 2,383 2,735 2,912 2,776 2,230
Tax assets 1,706 1,921 2,275 2,681 2,873
Equity method investments 924 970 1,040 1,094 920
Goodwill 4,556 4,556 4,556 4,583 4,589
Other intangible assets 842 814 789 757 742
Property, plant and equipment 3,944 4,355 4,728 5,093 5,493
Right-of-use assets 193 290 306 300 307
Total assets 36,300 35,148 36,929 37,514 39,958
Liabilities and shareholders' equity
Current liabilities 17,983 16,948 16,755 16,310 16,275
Non-current liabilities 9,506 8,413 9,569 9,209 10,231
Shareholders' equity 8,811 9,787 10,605 11,995 13,452
Total liabilities and shareholders' equity 36,300 35,148 36,929 37,514 39,958
These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.

-- 22 of 24 --

Public
Page 23	January 24, 2024
This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including
statements with respect to plans, strategies, expected trends, including trends in the semiconductor industry and end markets and business environment trends, including
expected demand, utilization, inventory levels, backlog, bookings, expected recovery in the semiconductor industry and expected timing thereof, assumptions and expectations
with respect to fast shipments, plans to increase capacity, outlook and expected financial results, including expected results for Q1 2024, including net sales, gross margin,
R&D costs, SG&A costs, expected results for full year 2024, including expectations with respect to revenue and gross margin and estimated annualized effective tax rate,
expectations with respect to sales by market segment and EUV, non-EUV and IBM sales and expected drivers thereof, and other full year 2024 expectations, expectations
with respect to revenue growth in 2025 and expected drivers thereof, statements made at our 2022 Investor Day, including revenue and gross margin opportunity for 2025 and
2030, statements with respect to export control policy and regulations and expected impact on us, expectation to return significant amounts of cash to shareholders through
growing dividends and share buybacks, including the amount of shares intended to be repurchased under the program and statements with respect to dividends, statements
with respect to our ESG goals and strategy and other non-historical statements. You can generally identify these statements by the use of words like “may”, “will”, “could”,
“should”, “project”, “believe”, “anticipate”, “expect”, “plan”, “estimate”, “forecast”, “potential”, “intend”, “continue”, “target”, “future”, “progress”, “goal”, “opportunity”, “potential”
and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and
projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future
performance and involve a number of substantial known and unknown risks and uncertainties. These risks and uncertainties include, without limitation, customer demand and
semiconductor equipment industry capacity, worldwide demand for semiconductors and semiconductor manufacturing capacity, utilization and inventory levels, general trends
and consumer confidence in the semiconductor industry, the impact of general economic conditions, including the impact of the current macroeconomic uncertainty on the
semiconductor industry, the impact of inflation, interest rates, geopolitical developments, the impact of pandemics, performance of our systems, the success of technology
advances and the pace of new product development and customer acceptance of and demand for new products, our production capacity and ability to adjust capacity to meet
demand, supply chain capacity, constraints and logistics, timely availability of parts and components, raw materials, critical manufacturing equipment and qualified employees,
and constraints on our ability to produce systems to meet demand, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order
cancellation or push outs and restrictions on shipment of ordered systems under export controls, risks relating to the trade environment, import/export and national security
regulations and orders and their impact on us, including the impact of changes in export regulations and the impact of such regulations on our ability to obtain necessary
licenses and to sell our systems to certain customers, changes in exchange and tax rates, available liquidity and liquidity requirements, our ability to refinance our
indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, the number of shares repurchased under
our share repurchase programs, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation, our ability
to meet ESG goals and execute our ESG strategy, other factors that may impact ASML’s business or financial results, and other risks indicated in the risk factors included in
ASML’s Annual Report on Form 20-F for the year ended December 31, 2022 and other filings with and submissions to the US Securities and Exchange Commission. These
forward-looking statements are made only as of the date of this document. We undertake no obligation to update any forward-looking statements after the date of this report or
to conform such statements to actual results or revised expectations, except as required by law.
Forward looking statements

-- 23 of 24 --

Public

-- 24 of 24 --